Randall B. Brenner, Chief Development & Regulatory at Paratek Pharmaceuticals, Inc. (PRTK), sold 6,278 shares at $3.10 ($19K) on 2019-12-12, disclosed to the SEC on 2019-12-16.
Open-market sale of $19k PRTK by Chief Development & Regulatory. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PRTK | SELL | 2022-12-14 | $58K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $12K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $104K | — | Filing → |